Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,180,267 papers from all fields of science
Search
Sign In
Create Free Account
breast cancer prevention
Known as:
Prevention of Breast Cancer
, breast cancer preventions
, prevention breast cancer
Anything, such as drug administration or lifestyle changes, designed to inhibit the onset of breast cancer.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.
M. Munsell
,
B. Sprague
,
D. Berry
,
G. Chisholm
,
A. Trentham-Dietz
Epidemiologic Reviews
2014
Corpus ID: 18091808
To assess the joint relationships among body mass index, menopausal status, and breast cancer according to breast cancer subtype…
Expand
Review
2014
Review
2014
Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings
R. Chlebowski
,
Jisang Kim
,
R. Haque
Cancer Prevention Research
2014
Corpus ID: 8395391
Adherence to oral endocrine therapy in adjuvant breast cancer settings is a substantial clinical problem. To provide current…
Expand
Review
2011
Review
2011
Preventive therapy for breast cancer: a consensus statement.
J. Cuzick
,
A. Decensi
,
+9 authors
H. Zwierzina
The Lancet Oncology
2011
Corpus ID: 34535828
Review
2006
Review
2006
Estrogen receptors as therapeutic targets in breast cancer.
E. Ariazi
,
Jennifer L. Ariazi
,
Jennifer L. Ariazi
,
F. Cordera
,
V. Jordan
Current Topics in Medicinal Chemistry
2006
Corpus ID: 30915157
The estrogen receptor alpha (ERalpha) has proven to be the single most important target in breast cancer over the last 30 years…
Expand
Review
2006
Review
2006
Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention
R. Rudel
,
K. Attfield
,
Jessica N. Schifano
,
J. Brody
Cancer
2006
Corpus ID: 19518049
Identifying chemical carcinogens in animal studies is currently the primary means of anticipating cancer effects in humans…
Expand
Review
2006
Review
2006
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
S. Land
,
D. Wickerham
,
+9 authors
P. Ganz
Journal of the American Medical Association (JAMA…
2006
Corpus ID: 11761393
CONTEXT Tamoxifen has been approved for breast cancer risk reduction in high-risk women, but how raloxifene compares with…
Expand
Highly Cited
2002
Highly Cited
2002
Tamoxifen for breast cancer among hysterectomised women
Umberto Veronesi
,
Patrick Maisonneuve
,
Virgilio Sacchini
,
N. Rotmensz
,
Peter Boyle
The Lancet
2002
Corpus ID: 27515370
Review
2000
Review
2000
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology
B. Katzenellenbogen
,
I. Choi
,
+6 authors
J. Katzenellenbogen
Journal of Steroid Biochemistry and Molecular…
2000
Corpus ID: 46159993
Review
1995
Review
1995
Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus.
G. Colditz
,
Frazier Al
Cancer Epidemiology, Biomarkers and Prevention
1995
Corpus ID: 6320420
We have recently published a mathematical model of the etiology of breast cancer based on the data from the Nurses Health Study…
Expand
Highly Cited
1987
Highly Cited
1987
The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention.
L. Bernstein
,
R. Ross
,
R. Lobo
,
R. Hanisch
,
M. Krailo
,
B. Henderson
British Journal of Cancer
1987
Corpus ID: 16396718
Girls who engage in strenuous physical activity are often amenorrheic and have recently been reported to be at a reduced risk of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE